Urge lawmakers to pass SB 401 to finally hold big pharmaceutical companies accountable and make prescription drugs affordable for all Louisianans.
Louisiana families continue to face crushing prescription drug costs for cancer medicines, insulin, and other essential treatments. SB 401 would change that by creating the Louisiana Prescription Drug Affordability Board (PDAB) — a state panel that can review drug prices and recommend commonsense ways to make life-saving medications affordable.
This commonsense legislation would help patients, taxpayers, small businesses, and local pharmacies by addressing the true driver of high costs — pharmaceutical manufacturers who set unchecked prices. Pharmacies, doctors, hospitals, and insurers all operate downstream from those drug prices; SB 401 ensures accountability at the source.
By passing SB 401, Louisiana can:
Your voice matters. Tell your Louisiana state lawmakers to support SB 401 and help establish the Prescription Drug Affordability Board — a commonsense step toward lower drug prices, stronger local pharmacies, and better access for every Louisiana patient.
1 in 4 adults report difficulty affording prescription medications
Louisiana taxpayers spend an average of $1.1B a year on Medicaid prescription drugs, even after manufacturer rebates – based on the three most recent years of data (FY2021–2023). Driven by manufacturers’ list prices, these costs strain state budgets, taxpayers, and small businesses.
SB 401 gives Louisiana the power to take action against unaffordable drug costs.
✓ Your message will be delivered to your lawmakers
✓ We’ll keep you updated on Louisiana drug price accountability and prescription drug access legislation
✓ Your voice joins other Louisianans calling for drug price reform